PDXK and acute myeloid leukemia: We performed linear regression analysis on the experiments represented in “Fig 3B”, and we found that both CD33dim and CD33bright targets were eliminated in PKH+CD3negCD33+ AML blast cells (R2 = 0.12), (“Fig 3C”).